Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 13, 2020 - Issue
Submit an article Journal homepage
111
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Role of TNF-α and FGF-2 in the Fracture Healing Disorder of Type 2 Diabetes Model Induced by High Fat Diet Followed by Streptozotocin

Heqing HuangDepartment of Orthopaedics and Traumatology, Third Xiangya Hospital of Central South University, Changsha410013, Hunan Province, People’s Republic of China
,
Ling LuoDepartment of Orthopaedics and Traumatology, Third Xiangya Hospital of Central South University, Changsha410013, Hunan Province, People’s Republic of China
,
Zhitao LiuDepartment of Orthopaedics and Traumatology, Third Xiangya Hospital of Central South University, Changsha410013, Hunan Province, People’s Republic of China
,
Yan LiDepartment of Orthopaedics and Traumatology, Third Xiangya Hospital of Central South University, Changsha410013, Hunan Province, People’s Republic of China
,
Zhaochen TongDepartment of Orthopaedics and Traumatology, Third Xiangya Hospital of Central South University, Changsha410013, Hunan Province, People’s Republic of China
&
Zhendong LiuDepartment of Orthopaedics and Traumatology, Third Xiangya Hospital of Central South University, Changsha410013, Hunan Province, People’s Republic of ChinaCorrespondence[email protected]
Pages 2279-2288 | Published online: 30 Jun 2020

References

  • Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.002
  • Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313–320.
  • Hernandez RK, Do TP, Critchlow CW, et al. Patient-related risk factors for fracture-healing complications in the United Kingdom general practice research database. Acta Orthop. 2012;83(6):653–660. doi:10.3109/17453674.2012.747054
  • Tianquan Z, Quan A, Min F, et al. The application of streptozotomycinand high fat & sugar diet in rat type 2 diabetes mellitus model. J Hubei Inst Sci Technol. 2012;26(6):468–469.
  • Zhendong L, Jielin Z, Min G, et al. Distraction osteogenesis and early fracture healing in mice. Tissue Eng Res Clin Rehabil China. 2009;02:225–228.
  • Yasui N, Sato M, Ochi T, et al. Three modes of ossification during distraction osteogenesis in the rat. J Bone Joint Surg Br. 1997;79(5):824–830. doi:10.1302/0301-620X.79B5.0790824
  • Wang W, Zhang X, Zheng J, et al. High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway. Mol Cell Biochem. 2010;338(1–2):115–122. doi:10.1007/s11010-009-0344-6
  • Balint E, Szabo P, Marshall CF, et al. Glucose-induced inhibition of in vitro bone mineralization. Bone. 2001;28(1):21–28. doi:10.1016/S8756-3282(00)00426-9
  • Beutler B, Cerami A. Cachectin (Tumor Necrosis Factor): A Macrophage Hormone Governing Cellular Metabolism and Inflammatory Response[Z]. Endocrine Reviews.Vol. 9;1988: 57–66.
  • Suarez EC, Boyle SH, Lewis JG, et al. Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator. Brain Behav Immun. 2006;20(4):331–338. doi:10.1016/j.bbi.2005.09.005
  • Hotamisligil GS, Murray DL, Choy LN, et al. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994;91(11):4854–4858. doi:10.1073/pnas.91.11.4854
  • Kallel A, Ftouhi B, Jemaa Z, et al. Tumor necrosis factor-alpha (TNF-αlpha) −863C/A promoter polymorphism is associated with type 2 diabetes in Tunisian population. Diabetes Res Clin Pract. 2013;102(2):e24–e28. doi:10.1016/j.diabres.2013.09.015
  • Li J, Sarosi I, Yan XQ, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclasto genesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A. 2000;97(4):1566–1571. doi:10.1073/pnas.97.4.1566
  • Boyce BF, Li P, Yao Z, et al. TNF-α and pathologic bone resorption. Keio J Med. 2005;54(3):127–131. doi:10.2302/kjm.54.127
  • Huang H, Zhao N, Xu X, et al. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Prolif. 2011;44(5):420–427. doi:10.1111/j.1365-2184.2011.00769.x
  • Alblowi J, Kayal RA, Siqueria M, et al. High levels of tumor necrosis factor-α contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol. 2009;175(4):1574–1585. doi:10.2353/ajpath.2009.090148
  • Lim JC, Ko KI, Mattos M, et al. TNF-α contributes to diabetes impaired angiogenesis in fracture healing. Bone. 2017;99:26–38. doi:10.1016/j.bone.2017.02.014
  • Du X, Xie Y, Xian CJ, et al. Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol. 2012;227(12):3731–3743. doi:10.1002/jcp.24083
  • Kawaguchi H, Kurokawa T, Hanada K, et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin- diabetic rats. Endocrinology. 1994;135(2):774–781. doi:10.1210/endo.135.2.8033826
  • Facchiano F, D’Arcangelo D, Russo K, et al. Glycated fibroblast growth factor-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice. Mol Endocrinol. 2006;20(11):2806–2818. doi:10.1210/me.2005-0322

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.